Golimumab Lessened Sleep Disturbance in Ankylosing Spondylitis

Idsk -- The anti–tumor necrosis factor–alpha agent golimumab significantly reduced sleep disturbance and improved health-related quality of life in a randomized placebo-controlled trial of 356 patients with ankylosing spondylitis.